Emmaus Life Sciences, Inc. Quarterly Operating Margin in % from Q4 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Emmaus Life Sciences, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q3 2024.
  • Emmaus Life Sciences, Inc. Operating Margin for the quarter ending September 30, 2024 was 0.09 %, a 96.8% decline year-over-year.
  • Emmaus Life Sciences, Inc. annual Operating Margin for 2023 was 12 %.
  • Emmaus Life Sciences, Inc. annual Operating Margin for 2022 was -35.8 %, a 20.4% decline from 2021.
  • Emmaus Life Sciences, Inc. annual Operating Margin for 2021 was -29.7 %, a 21429% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 0.09 -2.61 -96.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -3.9 -4.19 -1433% Apr 1, 2024 Jun 30, 2024
Q1 2024 7.75 +29.1 Jan 1, 2024 Mar 31, 2024
Q4 2023 12 +47.8 Oct 1, 2023 Dec 31, 2023
Q3 2023 2.7 +68.2 Jul 1, 2023 Sep 30, 2023
Q2 2023 0.29 +58.6 Apr 1, 2023 Jun 30, 2023
Q1 2023 -21.4 +19.6 +47.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -35.8 -6.08 -20.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -65.5 -62.1 -1846% Jul 1, 2022 Sep 30, 2022
Q2 2022 -58.3 -55.1 -1709% Apr 1, 2022 Jun 30, 2022
Q1 2022 -41 -28.1 -217% Jan 1, 2022 Mar 31, 2022
Q4 2021 -29.7 -29.6 -21429% Oct 1, 2021 Dec 31, 2021
Q3 2021 -3.36 -4.66 -360% Jul 1, 2021 Sep 30, 2021
Q2 2021 -3.22 +12.5 +79.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -12.9 -4.52 -53.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -0.14 +19.7 +99.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 1.29 Jul 1, 2020 Sep 30, 2020
Q2 2020 -15.7 Apr 1, 2020 Jun 30, 2020
Q1 2020 -8.39 Jan 1, 2020 Mar 31, 2020
Q4 2019 -19.8 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.